Skip to main content
. 2017 Sep 21;16(5):1062–1071. doi: 10.5114/aoms.2017.70250

Table III.

Comparison of PLR, NLR, dNLR and LMR values between patients who survived and died during follow-up

Parameter Survivors N = 264 Cancer-specific deaths N = 91 Cancer-unrelated deaths N = 88 P-value (all groups) P-value (survivors vs. cancer-specific deaths) P-value (survivors vs. cancer-unrelated deaths) P-value (cancer-specific deaths vs. cancer-unrelated deaths)
PLR 117.8 (90.9–147.1) 176.3 (117.0–233.1) 138.3 (96.1–186.9) < 0.0001 < 0.0001 0.003 0.02
NLR 1.82 (1.39–2.36) 2.92 (2.18–4.09) 2.23 (1.6–3.31) < 0.0001 < 0.0001 0.002 0.0004
dNLR 1.33 (1.0–1.7) 1.77 (1.45–2.45) 1.61 (1.21–2.24) < 0.0001 < 0.0001 0.003 0.07
LMR 4.8 (3.76–6.0) 3.07 (2.12–4.25) 3.76 (2.63–5.75) < 0.0001 < 0.0001 0.0004 0.02

Continuous variables are presented as median (interquartile range). PLR – platelet-lymphocyte ratio, NLR – neutrophil-lymphocyte ratio, dNLR – derived neutrophil-lymphocyte ratio, LMR – lymphocyte-monocyte ratio.